Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Map4k1 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of MAP4K1 mRNA | CTD | PMID:22206623 | Map4k1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4K1 mRNA | CTD | PMID:17942748 | Map4k1 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of MAP4K1 mRNA | CTD | PMID:17942748 | Map4k1 | Rat | 17beta-estradiol | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | [Estradiol co-treated with IGF1R mutant form] results in increased expression of MAP4K1 mRNA | CTD | PMID:23094148 | Map4k1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4K1 mRNA | CTD | PMID:17942748 | Map4k1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAP4K1 mRNA | CTD | PMID:34747641 | Map4k1 | Rat | 2-butoxyethanol | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | n-butoxyethanol results in decreased expression of MAP4K1 mRNA | CTD | PMID:19812364 | Map4k1 | Rat | 2-palmitoylglycerol | increases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of MAP4K1 mRNA | CTD | PMID:37199045 | Map4k1 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Map4k1 (Mus musculus) | 6480464 | bisphenol S affects the methylation of MAP4K1 gene | CTD | PMID:31683443 | Map4k1 | Rat | 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Am 580 results in decreased expression of MAP4K1 mRNA | CTD | PMID:16982809 | Map4k1 | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Decitabine affects the expression of MAP4K1 mRNA | CTD | PMID:23300844 | Map4k1 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of MAP4K1 mRNA | CTD | PMID:31881176 | Map4k1 | Rat | aflatoxin B1 | increases methylation | ISO | MAP4K1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MAP4K1 gene; Aflatoxin B1 results in increased methylation more ... | CTD | PMID:28458013|PMID:30157460 | Map4k1 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | MAP4K1 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of MAP4K1 intron | CTD | PMID:30157460 | Map4k1 | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of MAP4K1 mRNA | CTD | PMID:35163327 | Map4k1 | Rat | antirheumatic drug | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of MAP4K1 mRNA | CTD | PMID:24449571 | Map4k1 | Rat | benzo[a]pyrene | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MAP4K1 mRNA | CTD | PMID:21569818|PMID:22610609 | Map4k1 | Rat | benzo[a]pyrene | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MAP4K1 mRNA | CTD | PMID:32417428 | Map4k1 | Rat | benzo[a]pyrene | affects methylation | ISO | MAP4K1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MAP4K1 intron; Benzo(a)pyrene affects the methylation of MAP4K1 promoter | CTD | PMID:27901495|PMID:30157460 | Map4k1 | Rat | benzo[a]pyrene | increases methylation | ISO | MAP4K1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of MAP4K1 exon | CTD | PMID:27901495 | Map4k1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of MAP4K1 mRNA | CTD | PMID:21318169 | Map4k1 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of MAP4K1 mRNA | CTD | PMID:21318169 | Map4k1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MAP4K1 mRNA | CTD | PMID:25181051 | Map4k1 | Rat | buta-1,3-diene | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | 1,3-butadiene results in decreased expression of MAP4K1 mRNA | CTD | PMID:29038090 | Map4k1 | Rat | Butylbenzyl phthalate | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased expression of MAP4K1 mRNA | CTD | PMID:28392331 | Map4k1 | Rat | cadmium dichloride | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of MAP4K1 mRNA | CTD | PMID:24982889 | Map4k1 | Rat | carbamazepine | affects expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of MAP4K1 mRNA | CTD | PMID:25979313 | Map4k1 | Rat | carbon nanotube | affects expression | ISO | Map4k1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog affects the expression of MAP4K1 mRNA | CTD | PMID:25554681 | Map4k1 | Rat | carbon nanotube | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of MAP4K1 mRNA | CTD | PMID:25554681 | Map4k1 | Rat | CGP 52608 | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MAP4K1 gene] | CTD | PMID:28238834 | Map4k1 | Rat | choline | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:20938992|PMID:33549593 | Map4k1 | Rat | cisplatin | affects expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Cisplatin affects the expression of MAP4K1 mRNA | CTD | PMID:23300844 | Map4k1 | Rat | cisplatin | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of MAP4K1 mRNA | CTD | PMID:27392435 | Map4k1 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of MAP4K1 mRNA | CTD | PMID:26033743 | Map4k1 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of MAP4K1 mRNA | CTD | PMID:26033743 | Map4k1 | Rat | crocidolite asbestos | affects expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Asbestos, Crocidolite affects the expression of MAP4K1 mRNA | CTD | PMID:17331233 | Map4k1 | Rat | cyanocob(III)alamin | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 | Map4k1 | Rat | dexamethasone | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Dexamethasone results in decreased expression of MAP4K1 mRNA | CTD | PMID:21041162 | Map4k1 | Rat | Dibutyl phosphate | affects expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of MAP4K1 mRNA | CTD | PMID:37042841 | Map4k1 | Rat | diethylstilbestrol | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Diethylstilbestrol results in decreased expression of MAP4K1 mRNA | CTD | PMID:14648872 | Map4k1 | Rat | dimethylarsinic acid | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Cacodylic Acid results in decreased expression of MAP4K1 mRNA | CTD | PMID:17720352 | Map4k1 | Rat | dimethylarsinic acid | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Map4k1 | Rat | dorsomorphin | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Map4k1 | Rat | entinostat | increases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | entinostat results in increased expression of MAP4K1 mRNA | CTD | PMID:27188386 | Map4k1 | Rat | epoxiconazole | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of MAP4K1 mRNA | CTD | PMID:35436446 | Map4k1 | Rat | folic acid | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:20938992|PMID:33549593 | Map4k1 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MAP4K1 mRNA | CTD | PMID:22061828 | Map4k1 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MAP4K1 mRNA | CTD | PMID:33387578 | Map4k1 | Rat | glycine betaine | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 | Map4k1 | Rat | hydrazine | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | hydrazine results in decreased expression of MAP4K1 mRNA | CTD | PMID:15282401 | Map4k1 | Rat | hypochlorous acid | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of MAP4K1 mRNA | CTD | PMID:19376150 | Map4k1 | Rat | L-methionine | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:20938992|PMID:33549593 | Map4k1 | Rat | lead(0) | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Lead results in decreased expression of MAP4K1 mRNA | CTD | PMID:19921347 | Map4k1 | Rat | lidocaine | increases expression | EXP | | 6480464 | Lidocaine results in increased expression of MAP4K1 mRNA | CTD | PMID:35283115 | Map4k1 | Rat | methyl methanesulfonate | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of MAP4K1 mRNA | CTD | PMID:23649840 | Map4k1 | Rat | methylarsonic acid | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Map4k1 | Rat | methylmercury chloride | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of MAP4K1 mRNA | CTD | PMID:28001369 | Map4k1 | Rat | Moniliformin | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | moniliformin results in decreased expression of MAP4K1 mRNA | CTD | PMID:39984025 | Map4k1 | Rat | monosodium L-glutamate | decreases expression | EXP | | 6480464 | Sodium Glutamate results in decreased expression of MAP4K1 mRNA | CTD | PMID:28954212 | Map4k1 | Rat | nickel atom | increases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Nickel results in increased expression of MAP4K1 mRNA | CTD | PMID:25583101 | Map4k1 | Rat | nitrates | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAP4K1 more ... | CTD | PMID:35964746 | Map4k1 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MAP4K1 mRNA | CTD | PMID:33387578 | Map4k1 | Rat | perfluorononanoic acid | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of MAP4K1 mRNA | CTD | PMID:25812627 | Map4k1 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of MAP4K1 mRNA | CTD | PMID:25812627 | Map4k1 | Rat | perfluorooctanoic acid | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of MAP4K1 mRNA | CTD | PMID:25812627 | Map4k1 | Rat | phenylmercury acetate | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of MAP4K1 mRNA | CTD | PMID:26272509 | Map4k1 | Rat | phenylmercury acetate | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Map4k1 | Rat | pirinixic acid | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929|PMID:20059764 | Map4k1 | Rat | pirinixic acid | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of MAP4K1 mRNA | CTD | PMID:20059764|PMID:23811191 | Map4k1 | Rat | quercetin | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of MAP4K1 mRNA | CTD | PMID:15309432 | Map4k1 | Rat | SB 431542 | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Map4k1 | Rat | silver atom | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Silver results in increased expression of MAP4K1 mRNA | CTD | PMID:27131904 | Map4k1 | Rat | silver(0) | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | Silver results in increased expression of MAP4K1 mRNA | CTD | PMID:27131904 | Map4k1 | Rat | sodium arsenate | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Map4k1 | Rat | sodium arsenate | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of MAP4K1 mRNA | CTD | PMID:39847705 | Map4k1 | Rat | sodium arsenite | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Map4k1 | Rat | sotorasib | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA | CTD | PMID:36139627 | Map4k1 | Rat | starch | multiple interactions | EXP | | 6480464 | Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of MAP4K1 mRNA] | CTD | PMID:27363782 | Map4k1 | Rat | sulfates | affects methylation | ISO | MAP4K1 (Homo sapiens) | 6480464 | Sulfates affects the methylation of MAP4K1 promoter | CTD | PMID:25395096 | Map4k1 | Rat | sulfates | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | [Soot co-treated with Sulfates] affects the methylation of MAP4K1 promoter | CTD | PMID:25395096 | Map4k1 | Rat | sunitinib | increases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of MAP4K1 mRNA | CTD | PMID:31533062 | Map4k1 | Rat | tamibarotene | increases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | tamibarotene results in increased expression of MAP4K1 mRNA | CTD | PMID:17229644 | Map4k1 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of MAP4K1 mRNA | CTD | PMID:31150632 | Map4k1 | Rat | thimerosal | decreases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of MAP4K1 mRNA | CTD | PMID:27188386 | Map4k1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of MAP4K1 mRNA | CTD | PMID:34492290 | Map4k1 | Rat | titanium dioxide | increases expression | ISO | Map4k1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of MAP4K1 mRNA | CTD | PMID:23557971 | Map4k1 | Rat | titanium dioxide | decreases expression | ISO | Map4k1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of MAP4K1 mRNA | CTD | PMID:27760801 | Map4k1 | Rat | trametinib | multiple interactions | ISO | MAP4K1 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA | CTD | PMID:36139627 | Map4k1 | Rat | triphenyl phosphate | decreases expression | EXP | | 6480464 | triphenyl phosphate results in decreased expression of MAP4K1 mRNA | CTD | PMID:30589522 | Map4k1 | Rat | valproic acid | increases methylation | ISO | MAP4K1 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of MAP4K1 gene | CTD | PMID:29154799 | Map4k1 | Rat | valproic acid | increases expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MAP4K1 mRNA | CTD | PMID:37505509 | Map4k1 | Rat | valproic acid | affects expression | ISO | MAP4K1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MAP4K1 mRNA | CTD | PMID:25979313 | Map4k1 | Rat | zinc atom | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 | Map4k1 | Rat | zinc(0) | multiple interactions | ISO | Map4k1 (Mus musculus) | 6480464 | [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B more ... | CTD | PMID:33549593 | | |||||||||||||||||||||||||||||||||||||||||||||||||






















